ABOUT
Symbiotix develops molecular therapeutics based on the human microbiome. Symbiotix Biotherapies was founded in 2009. Symbiotix Biotherapies' headquarters is located in Boston, Massachusetts, USA 02110.
Symbiotix Biotherapies' President & CEO, Nader Y... Symbiotix Biotherapies's President & CEO, Nader Yaghoubi, currently has an approval
rating of 70%. Symbiotix Biotherapies's primary competitors are
There are no competitors identified for Symbiotix Biotherapies
There have been no acquisitions found related to Symbiotix Biotherapies
Recent investment data cannot be found related to Symbiotix Biotherapies